This Is It!

I am so excited for the new company that I have joined is going to beenefit those who join me in a dramatic way.

If you have chiari, are disabled, know how to talk on the phone and are not satisfied with living on social security, check out my link www.yoliway.com. This company is the real thing. I have been in the network marketing industry with modest success, but lugging product to shows is not an option for me anymore.

How easy will this be for you? Just watch the webinars at http://www.yoliway.com Do your due dilligence. I know the owners of Yoli and they are a company that I can be proud to associate myself with.

If you have any questions at all, you can email me or call. Leave a message, if need be and I will get back with you. Get in at the beginning of this new dynamic company.

I am going to be going through physical rehabilitation in Chicago at the RIC. The Rehabilitation Institute of Chicago. I can guarantee you that I will be poping the blast caps into my water bottle after some intensive training. Can you imagine the health care professionals that are going to see me drinking a healthy drink, rather than a corn syrup laden sports drink?

Will update you soon!

Blessings, Linda Covert

Disabled? Work from Home, Just Like Me.......

Watch as Dave Bradbury shares Yoli, "THE NEXT BIG BRAND" in the Network Marketing Industry.

Get positioned today at www.yoliway.com

Yoli and the Blast Cap Technology is poised to turn the beverage industry on it's ear.

Discover The Next Big Brand!

Yoli has a Brand-New, Patented "Healthy Beverage" Technology that is poised to be HUGE competition to the "MLM Juice" industry.

Some of the TOP MINDS in the world of Network Marketing and the Home Based Business Industry have joined forces to create the Most Exciting & Lucrative MLM Opportunity EVER.

Learn why ALL other MLM Companies are literally shaking in their boots!

Learn why Top Tier Marketers from Top Tier companies are flocking to this like children lining up at the ICE CREAM Truck.

Get positioned today at www.yoliway.com
* Patented Blast Cap Technology!
* Live Active Ingredients!
* 100% Natural!
* AlkaPlex™ Patented Formula!
* No Sugar (uses Herbal Sweetener Stevia Reb-A)!
* Up to 6 servings of Fruits & Vegetables!
* Zero Glycemic Index!
* Natural Flavoring & Coloring!
* High ORAC Values!


Don't miss this OPPORTUNITY OF A LIFETIME!

Bill Gates says "Successful people recognize Trends and Timing and take immediate and massive action"

Get positioned today at www.yoliway.com
We will Train, Mentor, and Lead you to Success with Yoli.

Call Today!208-232-1431

Medtronic SHUNT Recall

Attention: I just read that the PV shunt that was used in shunting for hydrocephalus is being recalled. I am contacting my Neuro Surgeon regarding my shunt that was placed in 2007. It is a voluntary recall, meaning "they don't have to tell you"! I am sick of the FDA and physicians that don't contact their HUMAN patients. I had my surgery at the University of Utah and Dr. Brockmeyer was the surgeon. I am going to contact him tomorrow regarding the brand he used in my head.

Have a wonderful night. Linda

P.S. Remember to check out: http://www.covertchocolate.com and http://www.supersoygifts.com

News Release

Medtronic Media Contacts:

Jeff Warren, Investor Relations, 763-505-2696
Chuck Grothaus, Public Relations, 763-505-2614

FDA Classifies Medtronic Voluntary February Recall For BioGlide® Ventricular Snap Shunt Catheters (Models 27782, 27708 And 27802) As Class I

MINNEAPOLIS – March 27, 2009 – Medtronic, Inc. (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) classified as Class I its voluntary recall action initiated on February 11, 2009 of its BioGlide® Ventricular Snap Shunt Catheter (Cat. #s 27782, 27708 and 27802) – the cerebral ventricular catheter component of a shunt for the treatment of hydrocephalus. FDA defines Class I recalls as, “a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.” This recall action (applicable to units in the United States, Ireland and Australia) involved the retrieval of unused product and safety notification of implanted product of these three catalog numbers of Medtronic Cerebral Ventricular Catheters. Approximately 3,000 catheters have been distributed between 2002 and 2009. It is estimated that there are 300 unused catheters.

As of March 18, 2009, Medtronic completed contact with all users of these catheters. This was completed by visit from its field personnel delivering the recall notification and to retrieve unused products. In addition, Medtronic has notified all its U.S. customers even though they may not have received the affected product. Patients with the implanted shunt system not experiencing symptoms of shunt malfunction should continue to be managed under the standard patient management protocols. If a disconnection occurs, patients may present with a return of the symptoms of hydrocephalus and should be assessed in accordance with standard of care for assessment of shunt malfunction.

The recall involved the following models:
- Innervision Snap Shunt Ventricular Catheter, BioGlide®, Catalog Number 27782
- Snap Shunt Ventricular Catheter, BioGlide®, Catalog Number 27802
- Snap Shunt Ventricular Catheter, BioGlide®, Catalog Number 27708

It has been determined from nine reports of disconnected catheters requiring revision surgery, that the listed ventricular catheters may become detached from the snap base assembly after implantation and that this condition may increase the need for emergency revision surgery. There have been no reports of patient death or permanent serious injury as a result of this issue.

Consequences for a patient with failure of a ventricular catheter may include: nausea, vomiting, headache, lethargy, change in mental status, seizures, visual disturbance, and other more serious conditions. Patients with questions are encouraged to talk with their physician or contact Medtronic Neurosugery at 1-805-571-8400, Monday – Friday, 8 a.m. to 5 p.m. CDT. Physicians with medical questions related to this issue or Medtronic therapies should contact Medtronic at 1-800-328-0810, Monday – Friday, 8 a.m. to 5 p.m. CDT.

Any adverse reactions experienced with the use of this product, and/or quality problems can also be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 25, 2008. Actual results may differ materially from anticipated results.

- end -

---

Medtronic, Inc. 2009